Behold the possibilities of emerging therapies

Behold the possibilities of emerging therapies

Today, numerous clinical trials are either completed or underway for the treatment of different types of inherited retinal diseases, such as retinitis pigmentosa, X-linked retinitis pigmentosa (XLRP), Leber congenital amaurosis (LCA), achromatopsia (ACHM), Usher syndrome and Stargardt disease. These trials explore the potential of gene therapy and several other technologies.[1][2][3][4][5][6]

After receiving your results, your genetic counsellor and eye specialist may recommend extra steps to find out if you are eligible for a clinical trial or approved therapy.

Learn more about ongoing trials here.

Science is advancing the future of inherited retinal disease treatment

Many gene therapy innovations are now being studied. Each therapy (below) is designed to affect genes associated with inherited retinal disease in a specific way.[2][7][8]

DNA plus icon

Gene augmentation therapy

works by replacing mutated genes with new normal copies of that gene

Gene icon

Gene editing

corrects the gene variant directly, instead of delivering a new gene

Gene editing icon

RNA (ribonucleic acid) editing

fixes the instructions required to create proteins

See what’s possible when you test or retest.

Ask your eye specialist about genetic testing today.

More answers lie in our genes

While you can’t change what you inherit, you may find answers that can help put you in control of your future.

Microscope icon
5 simple steps to test

Know what to expect before, during, and after your genetic test or retest.


Public Health - Union Register of Medicinal Products. Union Register of medicinal products for human use. 2021. Available at: Last accessed: July 2023.
Bakall B et al. Ophthal Surg Lasers Imaging Retina. 2018; 49(7):472–478.
Vázquez-Domínguez I et al. Genes. 2019; 10(9):654.
Fry LE et al. Int J Mol Sci. 2020; 21(3):777.
Logo Janssen | Pharmaceutical Companies of Johnson & Johnson